Provectus grants ~49.5M stock options to CEO, President, CFO, CTO, directors; CFO salary raised to $200K

PROVECTUS BIOPHARMACEUTICALS, INC.

CEO Ed Pershing receives 25,470,215 options (grant date value $3,081,896) at $0.2862 exercise price.
President Dominic Rodrigues receives 16,146,600 options ($1,953,739); CFO Heather Raines receives 4,197,890 options ($507,945).
CFO base salary increased from $125,000 to $200,000 effective Dec 1, 2024; new employment agreement includes change-in-control provisions.
Options vest in three equal annual installments for officers; independent directors’ options vest immediately.
All option grants approved by Board on Nov 18, finalized Dec 2, 2024.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.